GLP-1 RAs Show Mixed Pancreatitis Risk

Early increase in suspected drug-induced cases offset by later lower rates of alcohol- and triglyceride-associated pancreatitis

Share

1

GLP-1 RAs did not increase acute pancreatitis risk vs sulfonylureas.
2

Study analyzed data from 333,687 patients (2017-2023).
3

Slight increased risk of suspected drug-induced pancreatitis in first 2 months.
4

Lower rates of alcohol and hypertriglyceridemia-associated pancreatitis observed later.
5

Majority of GLP-1 RA use was semaglutide.
6

Cohort mainly consisted of older males, limiting generalizability.
7

Early patient monitoring advised post-GLP-1 RA initiation.